CD38 and acute myeloid leukemia: The use of NSG PDX models has also led to a better understanding of the heterogeneity of leukemia-initiating cells (LIC) as reports identified the existence of not only CD34+CD38- LIC cells but also CD34+CD38+ and even CD34- populations capable of initiating AML (187, 188).